Linking pages
Linked pages
- Three F.D.A. Advisers Resign Over Approval of Alzheimer's Drug - The New York Times https://www.nytimes.com/2021/06/10/health/aduhelm-fda-resign-alzheimers.html 40 comments
- https://alz-journals.onlinelibrary.wiley.com/doi/full/10.1002/alz.12213 4 comments
- FDA’s Decision to Approve New Treatment for Alzheimer’s Disease | FDA https://www.fda.gov/drugs/news-events-human-drugs/fdas-decision-approve-new-treatment-alzheimers-disease 2 comments
- Biogen's Alzheimer’s Drug Poses a Dilemma for the F.D.A. - The New York Times https://www.nytimes.com/2021/06/05/health/alzheimers-aducanumab-fda.html 2 comments
- New Alzheimer’s Drug Could Cost the Government as Much as It Spends on NASA - The New York Times https://www.nytimes.com/2021/06/22/upshot/alzheimers-aduhelm-medicare-cost.html 2 comments
- https://investors.biogen.com/news-releases/news-release-details/biogen-and-eisai-launch-multiple-initiatives-help-patients 0 comments
Related searches:
Search whole site: site:www.nytimes.com
Search title: F.D.A. Approves Alzheimer’s Drug Despite Fierce Debate Over Whether It Works - The New York Times
See how to search.